Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Alexandre

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Acquisitions Medicales Recentes|January 1, 1972
[Therapeutic contributions of blocking and stimulation of the alpha and beta adrenergic receptors]J M Alexandre
British Journal of Pharmacology|May 1, 1980
Influence of beta-adrenoceptor blocking agents on the turnover rate of cardiac and splenic noradrenaline in ratsJ M Alexandre, C Chevillard
Lancet (London, England)|July 26, 1997
EMEA and third-generation oral contraceptivesJ M Alexandre, K Strandberg
La Revue De Medecine Interne|November 1, 1986
[Quality assurance of clinical trials]J M Alexandre, E Abadie
European Journal of Pharmacology|August 1, 1972
In vitro effects on cardiac norepinephrine of angiotensin II and of two indirectly acting sympathomimetic amines (amphetamine and tyramine). A study of their combinationsC Chevillard, J M Alexandre
Coeur Et Medecine Interne|January 1, 1972
[Pharmacological basis of the clinical use of antihypertensive agents]J Ménard, J M Alexandre, P Milliez
La Revue Du Praticien|February 11, 1973
[The pharmacology of antihypertensive agents]J M Alexandre, J Ménard, P Milliez
The Journal of Pharmacy and Pharmacology|March 1, 1975
How does angiotensin II increase cardiac dopamine-beta-hydroxylation?C Chevillard, N Duchene, J M Alexandre
La Nouvelle Presse Medicale|December 31, 1975
[Editorial: Mechanisms of the antihypertensive action of beta-blocking agents]J M Alexandre, P Corvol, J Ménard
British Heart Journal|June 1, 1986
Reversible renal failure after combined treatment with enalapril and frusemide in a patient with congestive heart failureC Funck-Brentano, G Chatellier, J M Alexandre
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Acquisitions Medicales Recentes|January 1, 1972
[Therapeutic contributions of blocking and stimulation of the alpha and beta adrenergic receptors]J M Alexandre
British Journal of Pharmacology|May 1, 1980
Influence of beta-adrenoceptor blocking agents on the turnover rate of cardiac and splenic noradrenaline in ratsJ M Alexandre, C Chevillard
Lancet (London, England)|July 26, 1997
EMEA and third-generation oral contraceptivesJ M Alexandre, K Strandberg
La Revue De Medecine Interne|November 1, 1986
[Quality assurance of clinical trials]J M Alexandre, E Abadie
European Journal of Pharmacology|August 1, 1972
In vitro effects on cardiac norepinephrine of angiotensin II and of two indirectly acting sympathomimetic amines (amphetamine and tyramine). A study of their combinationsC Chevillard, J M Alexandre
Coeur Et Medecine Interne|January 1, 1972
[Pharmacological basis of the clinical use of antihypertensive agents]J Ménard, J M Alexandre, P Milliez
La Revue Du Praticien|February 11, 1973
[The pharmacology of antihypertensive agents]J M Alexandre, J Ménard, P Milliez
The Journal of Pharmacy and Pharmacology|March 1, 1975
How does angiotensin II increase cardiac dopamine-beta-hydroxylation?C Chevillard, N Duchene, J M Alexandre
La Nouvelle Presse Medicale|December 31, 1975
[Editorial: Mechanisms of the antihypertensive action of beta-blocking agents]J M Alexandre, P Corvol, J Ménard
British Heart Journal|June 1, 1986
Reversible renal failure after combined treatment with enalapril and frusemide in a patient with congestive heart failureC Funck-Brentano, G Chatellier, J M Alexandre
Pageof 6